Breaking News: ALNY – Market Insights, Analysis & Latest Updates

ALNY

Earnings call: Alnylam reports strong growth and pipeline progress

Alnylam Pharmaceuticals reported a 34% revenue growth in Q3 2024, driven by the TTR franchise and advancements in its clinical pipeline, reaffirming its 2024 guidance.

investing.com • 31/10/2024 - 18:42 PM

ALNY

Ainylam Pharmaceuticals shares tumble following study results, BridgeBio Pharma rises

Alnylam Pharma shares fell 11.5% after reporting HELIOS-B Phase 3 results for vutrisiran, despite meeting endpoints, while BridgeBio shares rose 12% amid competitive concerns.

investing.com • 30/08/2024 - 11:39 AM

Greed and Fear Index

Note: The data is for reference only.

Greed

Earnings call: Alnylam reports strong growth and pipeline progress

Ainylam Pharmaceuticals shares tumble following study results, BridgeBio Pharma rises

Currency